Active, Not Recruiting
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
NCT05126277
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
- Locations
-
- University Of Alabama Birmingham, Alabama, United States
- Advanced Medical Research La Palma, California, United States
- University of California Irvine Orange, California, United States
- School Of Medicine Sacramento, California, United States